BEAM
Beam Therapeutics
Halal Rating :
See Details
Last Price
$22.39
Last updated:
Market Cap
$1.86b
7D Change
-5.13%
1 Year Change
-53.25%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Nov. 6, 2023
Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2023 | $20.12m | $122.26m | - | $11.95m | 0.00% | 9.78% |
| March 31, 2023 | $24.21m | $123.14m | - | $9.96m | 0.00% | 8.09% |
| Dec. 31, 2022 | $20.36m | $109.02m | - | $7.61m | 0.00% | 6.98% |
Company Impact
Help us evaluate Beam Therapeutics's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.
Justification for our Halal Rating
Insights
| Name | Description | Password | Date Published |
|---|---|---|---|
| Are we buying Beam Therapeutics (BEAM)? | Privileged Article | subscribe for access | 05/05/2022 |